Logomark

Surgery & Traumatology

Hemorrhagic shock

Traumatic hemorrhage management involves a systematic approach to control bleeding and manage coagulopathy. Early identification and control of bleeding sources, balanced resuscitation, and management of trauma-induced coagulopathy (TIC) are crucial. Viscoelastic testing, such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM), guides hemostatic therapy and optimizes outcomes.

Non-traumatic hemorrhage management in critically ill patients requires optimal transfusion practices. Evidence-based thresholds for red blood cell (RBC) transfusion and the use of plasma, platelets, and fibrinogen are essential. Viscoelastic testing helps guide transfusion strategies and minimize adverse events, ensuring patient-centered care.

Diagnostic tests for coagulopathy, including TEG and ROTEM, provide real-time assessments of coagulation status. These tests enable personalized resuscitation strategies, guiding blood product administration and hemostatic therapy. Integration into damage control resuscitation (DCR) protocols improves outcomes by correcting coagulopathy and reducing mortality in trauma patients. Evidence-based algorithms further enhance the effectiveness of ROTEM-guided bleeding management, reducing unnecessary transfusions and improving patient safety.


Traumatic hemorrhage

Guideline

Traumatic hemorrhage

The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition

Rolf Rossaint et al., Critical Care (2023)

What’s inside

This sixth edition of the European guideline provides updated recommendations for managing major bleeding and coagulopathy in trauma patients, emphasizing evidence-based practices.

Why it’s relevant

Major bleeding and coagulopathy are leading causes of preventable death in trauma patients, requiring timely and effective interventions.

Key focus

  • Early identification and control of bleeding sources
  • Strategies for balanced resuscitation and transfusion protocols
  • Management of trauma-induced coagulopathy (TIC)
  • Use of viscoelastic testing to guide hemostatic therapy

Takeaway

The guideline highlights a systematic approach to managing bleeding and coagulopathy, integrating early hemorrhage control, targeted resuscitation, and advanced monitoring to improve outcomes in trauma patients.

Non-traumatic hemorrhage

Guideline

Non-traumatic hemorrhage

Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine

Alexander P. J. Vlaar et al., Intensive Care Medicine (2021)

What’s inside

This clinical practice guideline from the European Society of Intensive Care Medicine (ESICM) provides evidence-based recommendations for transfusion strategies in critically ill adults with bleeding.

Why it’s relevant

Optimal transfusion practices are crucial for managing bleeding in critically ill patients, balancing the risks of anemia and transfusion-related complications.

Key focus

  • Thresholds for red blood cell (RBC) transfusion in bleeding patients
  • Use of plasma, platelets, and fibrinogen in massive hemorrhage
  • Role of viscoelastic testing (e.g., TEG, ROTEM) in guiding transfusion
  • Strategies to minimize transfusion-related adverse events

Takeaway

The guideline emphasizes a patient-centered approach to transfusion, using evidence-based thresholds and advanced monitoring to optimize outcomes and reduce risks in critically ill bleeding patients.

Diagnostic tests for coagulopathy

Review

TEG & ROTEM

The Role of TEG and ROTEM in Damage Control Resuscitation

Jason B. et al., Shock (2021)

What’s inside

This article explores the role of thromboelastography (TEG) and rotational thromboelastometry (ROTEM) in damage control resuscitation (DCR) for trauma patients, focusing on their utility in guiding hemostatic therapy.

Why it’s relevant

TEG and ROTEM provide real-time, dynamic assessments of coagulation, enabling personalized resuscitation strategies to manage trauma-induced coagulopathy (TIC) effectively.

Key focus

  • Principles of TEG and ROTEM in assessing coagulation status
  • Role in guiding blood product administration and hemostatic therapy
  • Integration into DCR protocols for trauma patients
  • Evidence supporting improved outcomes with TEG/ROTEM-guided resuscitation

Takeaway

The article highlights the value of TEG and ROTEM in optimizing DCR, enabling targeted interventions to correct coagulopathy and reduce mortality in trauma patients.

Review

ROTEM

The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management

Klaus Görlinger et al., Korean Journal of Anesthesiology (2019)

What’s inside

This article discusses the use of evidence-based algorithms for rotational thromboelastometry (ROTEM)-guided bleeding management, focusing on their application in perioperative and critical care settings.

Why it’s relevant

ROTEM-guided algorithms enable personalized, goal-directed hemostatic therapy, improving outcomes in patients with bleeding disorders.

Key focus

  • Principles of ROTEM and its parameters for coagulation assessment
  • Development and implementation of ROTEM-based algorithms
  • Clinical applications in cardiac surgery, trauma, and critical care
  • Evidence supporting reduced transfusion requirements and improved outcomes

Takeaway

The article highlights the effectiveness of ROTEM-guided algorithms in optimizing bleeding management, reducing unnecessary transfusions, and enhancing patient safety.

Previous
General approach to trauma ...

Disclaimer

The information on this website is provided for informational and educational purposes only and is intended exclusively for use by medical professionals. It does not constitute professional medical advice, diagnosis, or treatment.

B-QON accepts no liability for decisions made or actions taken based on the information provided on this website. Users are responsible for verifying the accuracy and applicability of all content and for consulting qualified medical professionals before making any clinical decisions.

By using this website, you agree to these terms. For more information, please see our Terms and Conditions.